Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways
Open Access
- 18 February 2023
- journal article
- research article
- Published by MDPI AG in Bioengineering
- Vol. 10 (2) , 269
Abstract
Chemotaxis, regulated by oscillatory signals, drives critical processes in cancer metastasis. Crucial chemoattractant molecules in breast cancer, CXCL12 and EGF, drive the activation of ERK and Akt. Regulated by feedback and crosstalk mechanisms, oscillatory signals in ERK and Akt control resultant changes in cell morphology and chemotaxis. While commonly studied at the population scale, metastasis arises from small numbers of cells that successfully disseminate, underscoring the need to analyze processes that cancer cells use to connect oscillatory signaling to chemotaxis at single-cell resolution. Furthermore, little is known about how to successfully target fast-migrating cells to block metastasis. We investigated to what extent oscillatory networks in single cells associate with heterogeneous chemotactic responses and how targeted inhibitors block signaling processes in chemotaxis. We integrated live, single-cell imaging with time-dependent data processing to discover oscillatory signal processes defining heterogeneous chemotactic responses. We identified that short ERK and Akt waves, regulated by MEK-ERK and p38-MAPK signaling pathways, determine the heterogeneous random migration of cancer cells. By comparison, long ERK waves and the morphological changes regulated by MEK-ERK signaling, determine heterogeneous directed motion. This study indicates that treatments against chemotaxis in consider must interrupt oscillatory signaling.Keywords
Funding Information
- National Institutes of Health (R01CA238042, U01CA210152, R01CA238023, R33CA225549, R50CA221807, R37CA222563)
- W.M. Keck Foundation (R01CA238042, U01CA210152, R01CA238023, R33CA225549, R50CA221807, R37CA222563)
This publication has 60 references indexed in Scilit:
- The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and MicroenvironmentBioMed Research International, 2013
- Targeting the EGFR signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- ERK-MAPK Drives Lamellipodia Protrusion by Activating the WAVE2 Regulatory ComplexMolecular Cell, 2011
- Origins of regulated cell-to-cell variabilityNature Reviews Molecular Cell Biology, 2011
- Cells navigate with a local-excitation, global-inhibition-biased excitable networkProceedings of the National Academy of Sciences, 2010
- Macrophage deficiency of p38α MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in miceJournal of Clinical Investigation, 2009
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growthBiochemical Journal, 2008
- EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalizationBreast Cancer Research and Treatment, 2005
- Quantile RegressionJournal of Economic Perspectives, 2001